ABSTRACT-Using the cannula inserting method, we investigated vascular responses to ACh and McN-A-343 (a Mi-agonist) in isolated and perfused canine and simian facial veins in non-preconstricted conditions. ACh usually induced only a vasoconstriction, but McN-A-343 did not induce any significant vasoconstriction. It is concluded that canine and simian facial veins contain very few receptors of the muscarinic M1-subtype; and according to previous studies, these vessels have abundant M3-receptors.
Previously, we showed that ACh induced only a vasoconstriction in isolated, perfused simian facial veins (1) . In that study, we considered that the ACh-induced vasoconstriction might be mostly mediated by muscarinic M3-receptors, because these receptors were readily suppressed by 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP, a M3-receptor antagonist). However, some participation of Ml-receptors could not be denied, because 4-DAMP also has M1-receptor antagonistic properties. In the present study, we attempted to examine the ACh-induced actions and effects of McN-A-343 (4-(m-chlorophenylcarbamoyloxy) -2-butynyltrimethyl ammonium chloride, a selective M1-agonist) on isolated canine and simian facial veins, using the cannula inserting method which was developed and modified by Hongo and Chiba in 1983 (2) and Tsuji and Chiba in 1984 (3) .
Mongrel dogs (n = 5) and Japanese monkeys (n = 2) of either sex, weighing 8 -15 kg and 3-6 kg, respectively, were anesthetized with sodium pentobarbital (30 mg/kg, i.v.) and ketamine hydrochloride (50 mg/kg, i.m.), respectively. After treatment with sodium heparin (200 units/kg, i.v.), the animals were sacrificed by rapid exsanguination from the right common carotid artery. Facial veins were then carefully isolated, small branches were ligated as much as possible, and segments (1.4-4.0 mm outer diameter and 15 -30 mm in length) were cut from each isolated vessel. We usually made two vessel preparations from each animal.
Each segment was inserted with a stainless steel cannula with three small side holes at a 5-mm distance from the distal blind end (21 -13 gauge with an outer diameter of 0.8-2.4 mm and 4 cm in length). The cannula with vascular segment was placed in a cup-shaped glass container maintained at 37°C and perfused with Krebs' solution at a constant flow rate (2.0 -4.0 ml/min) by means of a peristaltic pump. The perfusate contained 114 mM NaCI, 4.7 mM KCI, 2.5 mM CaC12, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3 and 11.1 mM glucose, and bubbled with 95% 02 and 5% CO2. The speed of perfusion was initially adjusted so that the perfusion pressure was maintained at 20 -40 mmHg and kept constant throughout the experiments. Therefore, the vasoconstriction or dilatation was observed as an increase or a decrease in perfusion pressure, respectively. The perfusion pressure was continuously measured with an electric manometer. The details of the cannula inserting method were described in previous papers (2, 3) .
When ACh was administered into the cannulated facial vein of the dog, the vasoconstrictor response was readily induced in a dose-related manner as shown in Fig. 1 . The threshold dose for inducing a vasoconstrictior was approximately 0.01,ug. McN-A-343 dic not induce significant vasoconstriction even al a large dose such as 100 ,u g. Summarized data are shown in Fig. 1 . In simian facial veins. ACh also induced vasoconstrictions in a fashion similar to that of canine veins as previously reported (1). McN-A-343 did not produce any vasoconstrictor response within 1C pg, although a slight vasodilation was induced at larger doses such as 100 ,ug. In these preparations, isoproterenol usually induced strong vasodilations even at a small dose such as 0.01 ,ug as reported previously (4) . Summarized data are shown in Fig. 2 .
The facial veins of rabbits (5), dogs (6). monkeys (1, 4) and human beings (7) maintain an intensive vascular tone in isolated and non-preconstricted conditions. Previously, we reported that ACh induced only a vasoconstriction, although isoproterenol and norepinephrine consistently produced a strong vasodilatation in isolated simian facial veins (1, 4) . The ACh-induced constrictions were usually much greater than phenylephrine-in- duced ones, and they were slightly but significantly inhibited by pirenzepine (a M1-receptor antagonist) but not influenced by AF-DX 116 (a M2-receptor antagonist) (1). Moreover, since 4-DAMP (a M3-receptor antagonist) strongly inhibited the ACh-induced constrictions, it was considered that the simian facial vein has abundant constrictory muscarinic receptors, especially the M3-subtype. The calculated approximate pA2 values in a previous paper (1) of atropine, pirenzepine and 4-DAMP were 9.2, 5.5 and 7.2, respectively, and AF-DX 116 did not modify the ACh-induced dose-response curve at a large dose of 100 pug. However, there still remained the possible participation of M1-receptors, because 4-DAMP also has M1-receptor antagonistic properties (8) .
In the present study, McN-A-343 did not induce a significant vasoconstriction in both canine and simian facial veins, although ACh consistently induced vasoconstrictions. MIN-A-343 has been proposed as a M1-selective agonist (9) , although it has been shown that certain effects of McN-A-343 are mediated by non-M1 muscarinic receptors (10) . Thus, it is demonstrated that ACh readily induced vasoconstrictions in not only simian but also canine facial veins and that the ACh-induced constrictions might be due to the activation of M3-receptors in isolated facial veins.
